2025 Annual Report
Annual Report
We’re Hiring: Join the ECETOC Team as a Trainee!
News

We’re Hiring: Join the ECETOC Team as a Trainee!

Are you passionate about science, regulatory toxicology, and making a real-world impact at the intersection of industry, academia, and policy? ECETOC is excited to announce that we’re looking for a...
ECETOC publishes a framework for the risk assessment of plastic additives
Press Release

ECETOC publishes a framework for the risk assessment of plastic additives

Part 1 sets out the fundamental elements, from problem formulation to risk characterisation.Brussels, 22 July 2026. The ECETOC Plastic Additives Task Force has published the first of two peer...
HSSD Tool

HSSD Tool

This software was developed by a consortium of partners to facilitate the uptake of novel approaches to estimate aquatic threshold concentrations (e.g. the concentration at which 5% of the species are exposed above their EC50, HC5).
The Human Exposure Assessment Tools Database (heatDB)

The Human Exposure Assessment Tools Database (heatDB)

heatdb is a public directory of exposure data sources as well as available tools for exposure
NanoApp

NanoApp

ECETOC’s NanoApp is a tool designed to define the boundaries of sets of similar nanoforms and to generate a justification for the REACH registration.
Targeted Risk Assessment (TRA)

Targeted Risk Assessment (TRA)

The Targeted Risk Assessment (TRA) estimates exposures to workers, consumers and the environment that arise during a series of events.
TRA Task Force – Worker branch

TRA Task Force – Worker branch

Why? The Worker TRA Task Force has been active since 2019, delivering projects that advance the scientific basis of the Worker Targeted Risk Assessment (TRA) tool. Its overarching objective is to e...
Immunotoxicity assessment: Addressing Challenges and Advancing Methodologies [Workshop → Task Force]​

Immunotoxicity assessment: Addressing Challenges and Advancing Methodologies [Workshop → Task Force]​

Why?Regulatory assessment of immunotoxic properties of chemicals is a complex and challenging task​ Limited regulatory guidance exists​ Lack of industry and regulatory knowledge​...
Chronic fish case studies towards an IATA

Chronic fish case studies towards an IATA

Why?Hazard and safety assessments for the pelagic compartment often rely on in vivo studies using a single fish species, raising ethical concerns and uncertainty in terms of extrapolation....
Press Release
02.03.2010

ECETOC’s guidance for the classification of carcinogens under GHS published in ‘Critical Reviews in Toxicology’

Last year an ECETOC task force finalised guidance on how to classify carcinogens under the criteria for a globally harmonised system of classification and labelling of chemicals (GHS) developed by the United Nations Conference on Environment and Development (UNCED). The paper has just been published in Critical Reviews in Toxicology (see latest publications).

With regard to carcinogenicity, GHS distinguishes between Category 1 (“known or presumed human carcinogens') and Category 2 (“suspected human carcinogens'). Category 1 carcinogens are divided into Category 1A (“known to have carcinogenic potential for humans'), based largely on human evidence, and 1B (“presumed to have carcinogenic potential for humans'), based largely on experimental animal data. Concerns have been raised that the criteria for applying these carcinogenicity classifications are not sufficiently well defined and potentially allow different conclusions to be drawn.

Classification under GHS, like other systems in place, is for hazard, there being no consideration of potency or risk assessment, including exposure considerations. Such elements are being taken into account in the ECETOC scheme. A wide range of carcinogenic potency can be observed both in human epidemiological studies and in animal experiments. The following cut-off values for high and low potency for different exposure scenarios are proposed:

Cut-off values for substances of high and low potency (based on guidance
values to assist in Category 1 and 2 classification for chronic toxicity; UN, 2007)

PotencyTumours/Key events
High potency<10mg/kg oral, <20mg/kg dermal, or inhalation <0.02mg/L vapour, <0.02mg/L dust/mist/fume
>low potency>10mg/kg oral, >20mg/kg dermal, or inhalation >50ppm gas,
>0.02mg/L vapour, > 0.02mg/L dust/mist/fume

figure 1

The ECETOC paper lays out a series of questions (shown in figure 2.) to be applied during the evaluation of data from experiments with rodents; epidemiological data which could lead to Category 1A are not considered in this scheme. Answers to each question can lead either to a classification decision or to the next question.

Stepwise approach to the classification of a substance, not otherwise classifiable as

Category 1A on the basis of epidemiology, as a carcinogen using the GHS criteria
Stepwise-approach-to-the-cl
figure 2

It is being pointed out that this process should only be implemented in an environment of informed scientific opinion. Detailed guidance is provided on how to address these questions in determining carcinogen classification. It was concluded that mode of action and potency are probably the most important of the above-mentioned factors. The scheme is illustrated with five case studies: thiamethoxam, melamine, dichlorvos, formaldehyde, and Sudan I.

Reference to the ECETOC scheme has been made in the report of the REACH Implementation Project - RIP 3.6 (on the introduction of the GHS guidelines into the new EU chemicals legislation).

The task force presented first concepts for wider input at EUROTOX 2007, at the ECETOC-organised session “Carcinogen Classification - Moving from a hazard to a risk-based system', and the final scheme at last year's European meeting of the Toxicology Forum.